-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Solventum, Raises Price Target to $101

Benzinga·08/06/2026 18:52:45
Listen to the news
UBS analyst Kevin Caliendo maintains Solventum (NYSE:SOLV) with a Buy and raises the price target from $95 to $101.